What we do
A Leader in Biomedical Image Analysis Solutions
At Gremse-IT, we develop and license Imalytics Preclinical—a powerful software platform for multimodal biomedical image analysis. In addition to our core product, we offer services including AI-powered biodistribution pipeline development, image analysis as a service, and custom OEM software solutions for imaging device manufacturers. Our mission is to help researchers accelerate discovery through efficient, intuitive, and high-quality image analysis tools.
Our mission is to make preclinical imaging effortless and intelligent -
Fueling faster innovation in biomedical research.
At Gremse-IT, we are pushing the boundaries of biomedical image analysis
by combining advanced computation and software development with an expert and experienced team.
Our vision is to accelerate and simplify image analysis for the biomedical research community.
In academic labs, we aim to minimize the time spent on manual processing so researchers can focus on what matters most—science, discovery, and innovation. By making image analysis intuitive, fast, and accessible, we empower teams to accelerate their path to breakthroughs.
For industry, pharma, and radiopharmaceutical labs, we strive to meet the high-throughput demands of modern research. Our goal is to shorten analysis time from days to hours, enabling faster decision-making and advancing the pace of drug development and therapeutic discovery. Imalytics is built to deliver both speed and precision at scale.
Ultimately, we want to contribute to getting life-changing therapies to patients faster
Our History
Dr. Felix Gremse founded the company and successfully commercialized his first software product ‘Imalytics Preclinical'.
Introduced advanced multimodal imaging features and GPU-accelerated processing with Imalytics 2.0, enhancing preclinical research capabilities.
Established as Gremse-IT GmbH and gained scientific recognition with a publication in Theranostics.
Began collaboration with MiLabs to integrate advanced BLF and FLT reconstruction workflows.
Expanded operations with the establishment of first office to support growing partnerships and R&D.
Released proprietary CT reconstruction software to improve image quality and quantitation accuracy.
Released Imalytics 3.0, featuring a revamped user interface, new 3D segmentation, and enhanced image fusion capabilities.
Introduced a new dosimetry module enabling absorbed dose estimation from PET/SPECT data for radiopharmaceutical development.
Expanded North American presence with a new office in Montreal, with a strong focus on machine learning and automation.
The Gremse-IT Team
Gremse-IT consisits of a team of 20+ engineers, developers and scientists
%20(1).png)
.png)
.png)
Trusted by leading experts
Gremse-IT is supported by
"We have found the Imalytics software to be easy to use and the support from Gremse IT is excellent. We were very impressed with the recently released voxel-based dosimetry module."
"The software is easy to learn and provides ready-to-use workflows for different applications."
"Imalytics is an optimal solution as the software offers ease of learning, rapid accessibility, and accommodates numerous users."
"The tools and applications you've developed on Imalytics are incredibly useful, easy to handle, and effective."
Supporting researchers worldwide with preclinical image analysis solutions
Software in over 200 imaging cores worldwide.
Stay up to date with the latest from Gremse-IT.
Explore our most recent publications, projects, upcoming events, and company news. This is your hub for everything new in preclinical imaging, including insights from our research collaborations and innovations in image analysis.
